Investigational Drug Details
| Drug ID: | D512 |
| Drug Name: | 2,4-thiazolidinedione |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB11898 |
| DrugBank Description: | Thiazolidinedione has been investigated for the treatment of Type 2 Diabetes, Diabetes Mellitus, and DIABETES MELLITUS, TYPE 2. |
| PubChem ID: | 5437 |
| CasNo: | 2295-31-0 |
| Repositioning for NAFLD: | Yes |
| SMILES: | O=C1CSC(=O)N1 |
| Structure: |
|
| InChiKey: | ZOBPZXTWZATXDG-UHFFFAOYSA-N |
| Molecular Weight: | 117.12 |
| DrugBank Targets: | |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|